John M. Starcher's most recent trade in Pediatrix Medical Group Inc was a trade of 11,427 Common Stock done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pediatrix Medical Group Inc | John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 11,427 | 66,064 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 54,637 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 10,965 | 36,277 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 8,480 | 25,312 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | John M. Starcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 4,885 | 16,832 (0%) | 0% | 0 | Common Stock |